Please check your internet connection and try again.
# Hepamerz (l-Ornithine l-Aspartate)
## Overview
Hepamerz is a combination of two amino acids, l-ornithine and l-aspartate, used primarily in the management of hepatic encephalopathy. It is believed to promote the detoxification of ammonia in the liver and brain.
## Primary Indications
* Hepatic encephalopathy (overt and subclinical) associated with liver cirrhosis.
## Adult Dosing
* **Oral:** Typically 3 to 6 grams three times daily. Maximum daily dose is generally considered to be 18 grams.
* **Intravenous (IV):** Common dosage regimens include 5 grams to 10 grams infused over 30 minutes to several hours, up to 25 grams per day, depending on the severity of hepatic encephalopathy and local protocols. Consult specific product labeling or institutional guidelines for precise IV dosing.
## Pediatric Dosing
* Data on pediatric use is limited. Dosing should be individualized under specialist supervision and based on available literature, which is not standardized.
## Dose Adjustments
* No specific dose adjustments are routinely recommended for renal or hepatic impairment, as the drug is primarily used in patients with liver disease. However, caution is advised in severe hepatic dysfunction and patients with impaired kidney function.
## Contraindications
* Hypersensitivity to l-ornithine or l-aspartate.
* Severe kidney disease.
## Adverse Effects
* Nausea, vomiting, abdominal discomfort, diarrhea.
* Rarely, rash or increased liver enzymes.
## Key Drug Interactions
* No significant drug interactions have been widely reported. However, concurrent use with other substances affecting ammonia metabolism should be approached with caution.
## Monitoring
* Clinical assessment of hepatic encephalopathy symptoms (e.g., confusion, asterixis).
* Electrolytes and renal function, especially in patients with pre-existing kidney issues or severe dehydration.
## Clinical Pearls
* Often used as an adjunct to standard therapy for hepatic encephalopathy.
* Treatment duration may vary significantly depending on patient response and clinical judgment.
* Oral administration is generally preferred for chronic management, while IV is used for acute or severe episodes.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for comprehensive prescribing information. Always verify current drug information, dosages, and safety guidelines with the official product labeling and consult with relevant specialists before initiating or modifying therapy.
